Implications of polycystic ovary syndrome on oocyte development

Seminars in Reproductive Medicine

Volumn 26, Issue 1, 2008, Pages 53-61

  Dumesic, Daniel A ^a,b,c   Abbott, David H ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Reproductive Medicine and Infertility Associates   (United States)

Author keywords

Follicle development; Hyperandrogenism; Hyperinsulinemia; Oocyte maturation; Polycystic ovary syndrome

Indexed keywords

ACTIVIN; ACTIVIN A; BONE MORPHOGENETIC PROTEIN 15; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR 9; INHIBIN; INHIBIN A; INHIBIN B; MYELOPID; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; EMBRYO DEVELOPMENT; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; GENE EXPRESSION; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RESISTANCE; MEIOSIS; MICROENVIRONMENT; NIDATION; NONHUMAN; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION; PARACRINE SIGNALING; PREGNANCY TERMINATION; PROTEIN FAMILY; RISK ASSESSMENT;

FEMALE; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; LUTEINIZATION; OOCYTES; OOGENESIS; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; TRANSFORMING GROWTH FACTOR BETA;

EID: 38149085271     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992925     Document Type: Article

References (96)

1. Hutt KJ, McLaughlin EA, Holland MK. Kit ligand and c-Kit have diverse roles in mammalian oogenesis and folliculogenesis. Mol Hum Reprod 2006;12:61-69
2. McNatty KP, Smith P, Moore LG, et al. Oocyte-expressed genes affecting ovulation rate. Mol Cell Endocrinol 2005;234:57-66
3. Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 2001;15:854-866
4. Su YQ, Wu X, O'Brien MJ, et al. Synergistic roles of BMP15 and GDF9 in the development and function of the oocyte-cumulus cell complex in mice: genetic evidence for an oocyte-granulosa cell regulatory loop. Dev Biol 2004;276:64-73
5. Sutton ML, Gilchrist RB, Thompson JG. Effects of in-vivo and in-vitro environments on the metabolism of the cumulus-oocyte complex and its influence on oocyte developmental capacity. Hum Reprod Update 2003;9:35-48
6. Sugiura K, Eppig JJ. Society for Reproductive Biology Founders' Lecture. Control of metabolic cooperativity between oocytes and their companion granulosa cells by mouse oocytes. Reprod Fertil Dev 2005;17:667-674
7. Schramm RD, Bavister BD. A macaque model for studying mechanisms controlling oocyte development and maturation in human and nonhuman primates. Hum Reprod 1999;14:2544-2555
8. Dumesic DA, Schramm RD, Abbott DH. Early origins of polycystic ovary syndrome (PCOS). Reprod Fertil Dev 2005;17:349-360
9. Heijnen EMEW, Eijkemans MJC, Hughes EG, et al. A meta-analysis of outcomes of conventional IVF in women with polycstic ovary syndrome. Hum Reprod Update 2006;12:13-21
10. Sengoku K, Tamate K, Takuma N, et al. The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod 1997;12:474-477
11. Ludwig M, Finas DF, Al-Hasani S, et al. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 1999;14:354-358
12. Cano F, Garcia-Velasco JA, Millet A. Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet 1997;14:254-260
13. Faddy MJ, Gosden RG. Modelling the dynamics of ovarian follicle utilization throughout life. In: Trounson AO, Gosden RG, eds. Biology and Pathology of the Oocyte. Role in Fertility and Reproductive Medicine. Cambridge, UK: Cambridge University Press; 2003:44-52
14. Gougeon A. The early stages of folliclar growth. In: Trounson AO, Gosden RG, eds. Biology and Pathology of the Oocyte. Role in Fertility and Reproductive Medicine. Cambridge, UK: Cambridge University Press; 2003:29-43
15. Durlinger ALL, Gruijters MJ, Kramer P, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-1084
16. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypothesis. Endocr Rev 1996;17:121-155
17. Rice S, Ojha K, Whitehead S, et al. Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-mullerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries. J Clin Endocrinol Metab 2007;92:1034-1040
18. Jakimiuk AJ, Weitsman SR, Brzechffa PR, et al. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod 1998;4:1-8
19. Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the 'two-cell, two-gonadotropin' model revisited. Mol Cell Endocrinol 1994;100:51-54
20. Zachow RJ, Magoffin DA. Ovarian androgen biosynthesis: paracrine/autocrine regulation. In: Azziz R, Nestler JE, Dewailly D, eds. Androgen Excess Disorders in Women. Philadelphia, PA: Lippincott-Raven; 1997:13-22
21. Willis DS, Watson H, Mason HD, et al. Premature response to LH of granulosa cells from anovulatory women with polycystic ovaries: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998;83:3984-3991
22. Latham KE. Epigenetic modification and imprinting of the Mamm Genome during development. Curr Top Dev Biol 1999;43:1-49
23. Moor RM, Dai Y, Lee C, et al. Oocyte maturation and embryonic failure. Hum Reprod Update 1998;4:223-236
24. Albertini DF. Origins and manifestations of oocyte maturation competencies. Reprod Biomed Online 2003;6:410-415
25. Bachvarova R. Gene expression during oogenesis and oocyte development in mammals. In: Browder LW, ed. Developmental Biology: A Comprehensive Synthesis. New York, NY: Plenum; 1985;1:453-524
26. Wickramasinghe D, Ebert KM, Albertini DF. Meiotic competence acquisition is associated with the appearance of M-phase characteristics in growing mouse oocytes. Dev Biol 1991;143:162-172
27. Fair T, Hyttel P, Greve T, et al. Nucleus structure and transcriptional activity in relation to oocyte diameter in cattle. Mol Reprod Dev 1996;43:503-512
28. Pavlok A, Lucas-Hahn A, Niemann H. Fertilization and developmental competence of bovine oocytes derived from different categories of antral follicles. Mol Reprod Dev 1992;31:63-67
29. Su YQ, Sugiura K, Woo Y, et al. Selective degradation of transcripts during meiotic maturation of mouse oocytes. Dev Biol 2007;302:104-117
30. Gandolfi TA, Gandolfi F. The maternal legacy to the embryo: cytoplasmic components and their effects on early development. Theriogenology 2001;55:1255-1276
31. Tomek W, Torner H, Kanitz W. Comparative analysis of protein synthesis, transcription and cytoplasmic polyadenylation of mRNA during maturation of bovine oocytes in vitro. Reprod Dornest Anim 2002;37:86-91
32. Assey RJ, Hyttel P, Greve T, et al. Oocyte morphology in dominant and subordinate follicles. Mol Reprod Dev 1994;37:335-344
33. Osborn JC, Moor RM. The role of steroid signals in the maturation of mammalian oocytes. J Steroid Biochem 1983;19:133-137
34. Mattioli M, Galeati G, Bacci ML, et al. Follicular factors influence oocyte fertilizability by modulating the intercellular cooperation between cumulus cells and oocyte. Gamete Res 1988;21:223-232
35. Hyttel P, Fair T, Callesen H, et al. Oocyte growth, capacitation and final maturation in cattle. Theriogenology 1997;47:23-32
36. Moor RM, Lee C, Dai YF, et al. Antral follicles confer developmental competence on oocytes. Zygote 1996;4:289-293
37. Schramm RD, Bavister BD. FSH-priming of rhesus monkeys enhances meiotic and developmental competence of oocytes matured in vitro. Biol Reprod 1994;51:904-912
38. Wynn P, Picton HM, Krapez JA, et al. Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in vitro maturation. Hum Reprod 1998;13:3132-3138
39. Ectors FJ, Vanderzwalmen P, Van Hoeck JV, et al. Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod 1997;12:2002-2005
40. Bergh C, Broden H, Lundin K, et al. Comparison of fertilization, cleavage and pregnancy rates of oocytes from large and small follicles. Hum Reprod 1998;13:1912-1915
41. Arnot AM, Vandekerckhove P, DeBono MA, et al. Follicular volume and number during in-vitro fertilization: association with oocyte developmental capacity and pregnancy rate. Hum Reprod 1995;10:256-261
42. Stebbins-Boaz B, Richter JD. Translational control during early development. Crit Rev Eukaryot Gene Expr 1997;7:73-94
43. Dumesic DA, Schramm RD, Bird IM, et al. Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving FSH therapy for in vitro fertilization. Biol Reprod 2003;69:1213-1219
44. Vendola KA, Zhou J, Adesanya OO, et al. Androgens stimulate early stages of follicle growth in the primate ovarian. J Clin Invest 1998;101:2622-2629
45. Weil SJ, Vendola K, Zhou J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998;83:2479-2485
46. Weil S, Vendola K, Zhou J, et al. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-2956
47. Vendola K, Zhou J, Wang J, et al. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum Reprod 1999;14:2328-2332
48. Vendola K, Zhou J, Wang J, et al. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 1999;61:353-357
49. Jonard S, Robert Y, Cortet-Rudelli C, et al. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18:598-603
50. Dumesic DA, Damario MA, Session DR, et al. Ovarian morphology and serum hormone markers as predictors of ovarian follicle recruitment by gonadotropins for in vitro fertilization. J Clin Endocrinol Metab 2001;86:2538-2543
51. Nelson VL, Qin K, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:5925-5933
52. Eden JA, Jones J, Carter GD, et al. Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles. Clin Endocrinol (Oxf) 1990;32:395-405
53. Webber LJ, Stubbs S, Stark J, et al. Formation and early development of follicles in the polycystic ovary. Lancet 2003;362:1017-1021
54. Maciel GA, Baracat EC, Benda JA, et al. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;89:5321-5327
55. Tesarik J, Mendoza C. Nongenomic effects of 17B-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995;80:1438-1443
56. Tesarik J, Mendoza C. Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism. Hum Reprod Update 1997;3:95-100
57. Andersen CY. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 1993;77:1227-1234
58. Jakimiuk AJ, Weitsman SR, Magoffin DA. 5a-Reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1999;84:2414-2418
59. Agarwal SK, Judd HL, Magoffin DA. A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:3686-3691
60. Dumesic DA, Schramm RD, Peterson E, et al. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab 2002;87:1111-1119
61. Zheng P, Wei S, Bavister BD, et al. 17β-estradiol and progesterone improve in-vitro cytoplasmic maturation of oocytes from unstimulated prepubertal and adult rhesus monkeys. Hum Reprod 2003;18:2137-2144
62. Dumesic DA, Schramm RD, Abbott DH. Steroid and oocyte development. In: Filicori M, ed. Updates in Infertility Treatment 2004. Bologna, Italy: Medimond; 2005:457-475
63. Foong SC, Abbott DH, Zschunke MA, et al. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome (PCOS) patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab 2006;91:2327-2333
64. Wood JR, Dumesic DA, Abbott DH, et al. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007;92:705-713
65. Hickey T. Androgen Receptor Mediated Activity in the Ovary: Implications for Polycystic Ovary Syndrome [Ph.D. thesis]. Adelaide, Australia: University of Adelaidem; 2006
66. Phy JL, Conover CA, Abbott DH, et al. Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab 2004;89:3561-3566
67. Samoto T, Maruo T, Ladines-llave C, et al. Insulin receptor expression in the follicular and stroma compartments of the human ovary over the course of follicular growth, regression, and atresia. Endocr J 1993;40:715-726
68. Kezele PR, Nilsson EE, Skinner MK. Insulin but not insulin-like growth factor-I promotes the primordial to primary follicle transition. Mol Cell Endocrinol 2002;192:37-43
69. Balen AH, Conway GS, Homburg R, Legro RS. Polycystic Ovary Syndrome. A Guide to Clinical Management. London, UK: Taylor & Francis; 2005:47-67
70. Franks S, Gilling-Smith C, Watson H, et al. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999;28:361-378
71. Franks S, Mason H, Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 2000;163:49-52
72. Eppig JJ, O'Brien MJ, Pendola FL, et al. Factors affecting the developmental competence of mouse oocytes grown in vitro: follicle stimulating hormone and insulin. Biol Reprod 1998;59:1445-1453
73. Jakimiuk AJ, Weitsman SR, Navab A, et al. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overproduced in thecal and granulosa cells from polycystic ovaries. Clin Endocrinol Metab 2001;86:1318-1323
74. Kjotrod SB, During VV, Carlsen SM. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 2004;19:1315-1322
75. Tang T, Glanville J, Orsi N, et al. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 2006;21:1416-1425
76. Legro RS, Barnhart HX, Schlaff WDet alCooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-566
77. Knight PG, Glister C. Local roles of TGF-β superfamily members in the control of ovarian follicle development. Anim Reprod Sci 2003;78:165-183
78. Elvin JA, Yan C, Matzuk MM. Ooeyte-expressed TGF-beta superfamily members in female fertility. Mol Cell Endocrinol 2000;159:1-5
79. Hayashi M, McGee EA, Min G, et al. Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 1999;140:1236-1244
80. Vitt UA, Hayashi M, Klein C, et al. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 2000;62:370-377
81. Hreinsson JG, Scott JE, Rasmussen C, et al. Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture. J Clin Endocrinol Metab 2002;87:316-321
82. Aaltonen J, Laitinen MP, Vuojolainen K, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 1999;84:2744-2750
83. Teixeira Filho FL, Baracat EC, Lee TH, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1337-1344
84. Stubbs SA, Hardy K, Da Silva-Buttkus P, et al. Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab 2005;90:5536-5543
85. Weenen C, Laven JS, Von Bergh AR, et al. Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83
86. Fanchin R, Louafi N, Lozano DHM, et al. Per-follicle measurements indicate that anti-mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril 2005;84:167-173
87. Eldar-Geva T, Margalioth EJ, Gal M, et al. Serum anti-mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 2005;20:1814-1819
88. Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999;140:5789-5798
89. Fortune JE. The early stages of follicular development: activation of primordial follicles and growth of preantral follicles. Anim Reprod Sci 2003;78:135-163
90. Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction 2001;121:503-512
91. Sadatsuki M, Tsutsumi O, Yamada R, et al. Local regulatory effects of activin A and follistatin on meiotic maturation of rat oocytes. Biochem Biophys Res Commun 1993;196:388-395
92. Norman RJ, Milner CR, Groome NP, et al. Circulating follistatin concentrations are higher and activin levels are lower in polycystic ovarian syndrome. Hum Reprod 2001;16:668-672
93. Eldar-Geva T, Spitz IM, Groome NP, et al. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Hum Reprod 2001;16:2552-2556
94. Schneyer AL, Fujiwara T, Fox J, et al. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone levels. J Clin Endocrinol Metab 2000;85:3319-3330
95. Lambert-Messerlian G, Taylor A, Leykin L, et al. Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin stimulation. Biol Reprod 1997;57:1211-1216
96. Welt CK, Taylor AE, Fox J, et al. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab 2005;90:5582-5587